Insider · CIK 0001366346
Lawrence J Jasinski
Files at LMAT (LEMAITRE VASCULAR INC), LFWD (Lifeward Ltd.). First filing Nov 22, 2024, latest May 11, 2026.
Lawrence J Jasinski files SEC Form 4 as director and CEO at LMAT (LEMAITRE VASCULAR INC), and also at LFWD (Lifeward Ltd.). Since Nov 22, 2024, Lawrence J Jasinski has reported 0 open-market buys worth $0 and 5 open-market sells worth $836k, the latest filed on May 11, 2026.
A track record needs three past buys with six months of prices behind them; Lawrence J Jasinski has 0, so none is measured yet.
The newest scored trade: sold $434k of LMAT on May 7, 2026, filed May 11, 2026, scored 42 (moderate). In the last 12 months: 0 buys worth $0 and 1 sell worth $434k.
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
LMAT: LEMAITRE VASCULAR INC
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
LFWD: Lifeward Ltd.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 42Moderate | LEMAITRE VASCULAR INC | $434k 3,943 shares | -46% | +37% from low-8% from high | |
| 44Moderate | LEMAITRE VASCULAR INC | $91k 976 shares | -17% | +21% from low-12% from high | |
| 25Weak | LFWDsell Lifeward Ltd. | $2,405 1,909 shares | -2% | 0% from low-64% from high | |
| 57Moderate | LEMAITRE VASCULAR INC | $289k 3,142 shares | -55% | - | |
| 30Weak | LEMAITRE VASCULAR INC | $20k 198 shares | -4% | - |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| May 7, 2026 | LMAT LEMAITRE VASCULAR, INC. | 3,943 0.02% of outstanding | $434k | May 7, 2026 | none |
| Aug 12, 2025 | LMAT LEMAITRE VASCULAR, INC. | 976 0.00% of outstanding | $91k | Aug 12, 2025 | none |
| Mar 4, 2025 | LMAT LEMAITRE VASCULAR INC | 3,142 0.01% of outstanding | $289k | Mar 4, 2025 | none |
Transactions
The newest 50 of 78 rows this insider has filed.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 6 | 35 d ago |
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 6 | 35 d ago |
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | 35 d ago |
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | 35 d ago |
| Sep 3, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +2 | $0.00 | $0 | 4 | 35 d ago |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 5 | Jun 5, 2026 |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | Jun 5, 2026 |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Jun 5, 2026 |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Jun 5, 2026 |
| Jun 4, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 3 | Jun 5, 2026 |
| May 7, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +1,069 | $47.19 | $50k | 6,868 | May 11, 2026 |
| May 7, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +924 | $54.65 | $50k | 7,792 | May 11, 2026 |
| May 7, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +865 | $101.12 | $87k | 8,657 | May 11, 2026 |
| May 7, 2026 | LMAT LEMAITRE VASCULAR INC | SOpen-market sale Common Stock | -3,943 | $110.00 | $434k | 4,714 | May 11, 2026 |
| May 7, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Stock Option (Right to Buy)derivative | -1,069 | $0.00 | $0 | 2,140 | May 11, 2026 |
| May 7, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Stock Option (Right to Buy)derivative | -924 | $0.00 | $0 | 1,848 | May 11, 2026 |
| May 7, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Stock Option (Right to Buy)derivative | -865 | $0.00 | $0 | 1,729 | May 11, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 5 | Mar 30, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 4 | Mar 30, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Mar 30, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Mar 30, 2026 |
| Mar 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 1 | Mar 30, 2026 |
| Feb 26, 2026 | LMAT LEMAITRE VASCULAR INC | AGrant or award Common Stock | +476 | $0.00 | $0 | 5,798 | Mar 2, 2026 |
| Feb 26, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +1 | $0.00 | $0 | 5,799 | Mar 2, 2026 |
| Feb 26, 2026 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -1 | $0.00 | $0 | 3 | Mar 2, 2026 |
| Dec 12, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +5 | $0.00 | $0 | 5,317 | Dec 15, 2025 |
| Dec 12, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +5 | $0.00 | $0 | 5,322 | Dec 15, 2025 |
| Dec 12, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -5 | $0.00 | $0 | 0 | Dec 15, 2025 |
| Dec 12, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -5 | $0.00 | $0 | 0 | Dec 15, 2025 |
| Dec 10, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Common Stock | +533 | $0.00 | $0 | 5,312 | Dec 11, 2025 |
| Dec 10, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Stock Option (Right to Buy)derivative | +3,431 | $0.00 | $0 | 3,431 | Dec 11, 2025 |
| Dec 8, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +2 | $0.00 | $0 | 4,776 | Dec 10, 2025 |
| Dec 8, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +3 | $0.00 | $0 | 4,779 | Dec 10, 2025 |
| Dec 8, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -2 | $0.00 | $0 | 4 | Dec 10, 2025 |
| Dec 8, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -3 | $0.00 | $0 | 4 | Dec 10, 2025 |
| Dec 6, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Common Stock | +1 | $0.00 | $0 | 4,774 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 7 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 6 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 6 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 7 | Dec 8, 2025 |
| Dec 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 4 | Dec 8, 2025 |
| Dec 6, 2025 | LMAT LEMAITRE VASCULAR INC | MOption exercise Dividend Equivalent Rightsderivative | -1 | $0.00 | $0 | 3 | Dec 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 7 | Sep 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 6 | Sep 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 5 | Sep 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 6 | Sep 8, 2025 |
| Sep 4, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +1 | $0.00 | $0 | 3 | Sep 8, 2025 |
| Aug 12, 2025 | LMAT LEMAITRE VASCULAR INC | SOpen-market sale Common Stock | -976 | $92.78 | $91k | 4,773 | Aug 14, 2025 |
| May 29, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 6 | Jun 2, 2025 |
| May 29, 2025 | LMAT LEMAITRE VASCULAR INC | AGrant or award Dividend Equivalent Rightsderivative | +0 | $0.00 | $0 | 5 | Jun 2, 2025 |
Questions about Lawrence J Jasinski
Answered from the filings on this page, as of the latest one.
Is Lawrence J Jasinski buying or selling?
In the last 12 months Lawrence J Jasinski reported 0 open-market buys worth $0 and 1 open-market sell worth $434k on SEC Form 4; the latest was sold $434k of LMAT on May 7, 2026. Grants, option exercises and tax withholding are not counted.
How did Lawrence J Jasinski's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Lawrence J Jasinski has 0.
Where does Lawrence J Jasinski file Form 4?
Lawrence J Jasinski has filed Form 4 at LMAT (LEMAITRE VASCULAR INC); LFWD (Lifeward Ltd.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.